Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head/Neck Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02145637
What this trial is testing

Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC
Yonsei University 30
Early research (Phase 1)Study completedNCT00404339
What this trial is testing

Vaccine Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Robert Ferris 17
Testing effectiveness (Phase 2)Looking for participantsNCT06190639
What this trial is testing

A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 31
Not applicableStudy completedNCT06031337
What this trial is testing

Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

Who this might be right for
Oral CancerOral Squamous Cell Carcinoma
Fayoum University 46
Early research (Phase 1)Study completedNCT00083057
What this trial is testing

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)UnknownNCT04978012
What this trial is testing

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Fudan University 48
Not applicableStudy completedNCT06730412
What this trial is testing

CtDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary 103
Testing effectiveness (Phase 2)Looking for participantsNCT07063212
What this trial is testing

Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Who this might be right for
Squamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more
Memorial Sloan Kettering Cancer Center 40
Not applicableLooking for participantsNCT06017895
What this trial is testing

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Swallowing-induced Pain
Nanfang Hospital, Southern Medical University 178
Testing effectiveness (Phase 2)Study completedNCT00519077
What this trial is testing

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
University of Chicago 44
Not applicableLooking for participantsNCT07080437
What this trial is testing

An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Three Gorges Hospital of Chongqing University 40
Not applicableEnrolling By InvitationNCT07234539
What this trial is testing

Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management

Who this might be right for
Thyroid CancerLarge Language Models
The University of Hong Kong 76
Not applicableLooking for participantsNCT04214119
What this trial is testing

EsophaCap for the Detection of Early Esophageal Carcinoma

Who this might be right for
Barrett EsophagusEsophageal CancerGastric Cancer
Johns Hopkins University 2,500
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Not applicableLooking for participantsNCT07823283
What this trial is testing

Continuous Monitoring of Microvascular Anastomoses: An Observational Trial

Who this might be right for
Head and Neck Neoplasm
Mayo Clinic 100
Testing effectiveness (Phase 2)Ended earlyNCT01806649
What this trial is testing

BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy

Who this might be right for
Esophageal Cancer
Prince of Songkla University 5
Very early researchStudy completedNCT02467738
What this trial is testing

Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer

Who this might be right for
Recurrent Head and Neck Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Not applicableStudy completedNCT03222440
What this trial is testing

Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)UnknownNCT06051747
What this trial is testing

Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea)

Who this might be right for
Thyroid Cancer
Ja Seong Bae, MD, phD 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07049185
What this trial is testing

QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 35
Next Page